Announcements Trials

Browse Landscape

Phase

Phase 2 16 Phase 1 6 Phase 1/2 5 Phase 3 4 Phase 4 2 Phase NA 1 Phase EARLY_PHASE1 1 Phase 2/3 1

Status

Completed 14 Unknown 4 Terminated 3 Withdrawn 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1 Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 17 Cyclophosphamide 16 fludarabine 12 Specimen Handling 12 Fluorodeoxyglucose F18 7 pembrolizumab 6 X-Rays 6 Nivolumab 6 Temozolomide 5 Radiotherapy 5 Immunotherapy, Adoptive 5 lenvatinib 4 Paclitaxel 4 Leukapheresis 4 Immune Checkpoint Inhibitors 4 Etoposide 4 Cisplatin 4 Carboplatin 4 ruxolitinib 3 fluciclovine F-18 3 Tirzepatide 3 Surgical Procedures, Operative 3 Doxorubicin 3 Dasatinib 3 Cholecalciferol 3 Biopsy 3 68Ga-FAPI 3 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 3 tislelizumab 2 palbociclib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Recruiting × Metformin × Clear all

NCT05515978 2025-12-04

PragMet

University of Colorado, Denver

Phase EARLY_PHASE1 Recruiting

Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡